Restrictions remain in place and inside all of our hospitals you still need to wear a mask, wash your hands and follow social distancing. Please see information for visitors > before you plan on visiting.
From Monday 16 March 2020, recruitment of patients to all studies, other than those studies relating to COVID-19, will cease. This is to allow our clinical colleagues to focus their care where it is most needed. We are reviewing the trials we have open and are in contact with sponsors. The safety of our patients it always our priority.
The Derby Clinical Trials Support Unit is provisionally registered by the UKCRC CTU Network. We provide a bespoke service to researchers, sponsors and industry partners - including small and medium enterprises - through the design, delivery, analysis and reporting of high quality clinical research.
Whether you require support for a specific service or full project management and delivery, we can help.
Our clinical trials unit supports a wide range of studies and trials.
Take a look at some of the CTU studies and trials that are in set up, open or have been completed.
Derby Clinical Trials Unit is provisionally
registered by the UKCRC.
60% of UK COVID-19 interventional trials* have involvement from UKCRC - registered trial units.
As a consultancy working with small and medium enterprises (SMEs) which innovate in healthcare, we recognise that our clients, seeking product validation through clinical trials, need to work with an organisation that is flexible, responsive, and cost-effective. For this reason we repeatedly refer clients to Derby Clinical Trials Support Unit, where our experience and client feedback is consistently excellent. I will not hesitate to continue such recommendations and referrals in future.
Kate Pym, Managing Director, Pym’s Consultancy.
As a health services researcher working with clinicians across the UK to recruit participants to clinical trials, it is important to have effective and efficient support from a reliable clinical trials unit. I have been impressed with the support from Derby CTSU, their quick response times, attention to detail, and also their flexible and pragmatic approach. I would highly recommend Derby CTSU and look forward to working with them for many years to come.
Professor Chris Littlewood, Manchester Metropolitan University
Our MAGIC2 study found an excellent home at the Derby CTSU. The team there have truly become partners on our journey and have actively helped to shape many aspect of our trial from day one, with success as our common goal.
MAGIC2 is a clinical investigation of a paediatric medical device, hence a particularly tricky one to handle, but to the Derby Team’s full credit, they are doing so magnificently.
Professor Luca Marciani
Chief Investigator, MAGIC2 study